Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 3,265-3,276 of 12,112
Drug study icon
RecruitingNCT06229210

Safety and Tolerability study of Lumateperone in Pediatric people with Schizophrenia, Bipolarity or Autism Spectrum Disorder

This study is recruiting. It focuses on bipolarity and currently lists participation information in Serbia and the United States.

Multiple locations, including Phoenix
Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 5 Years to 17 Years
Countries
United States, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
RecruitingISRCTN10974027

Safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of intravenous dosing of SPL026 drug product (N, N-dimethyltryptamine fumarate; DMT Fumarate [A Serotonergic Psychedelic]) alone or in combination with selective serotonin reuptake inhibitors in people with major depressive disorder

This study is recruiting in the United Kingdom. It focuses on depression.

In United Kingdom
DepressionOtherFrom 18 Years to 99 Years
Countries
United Kingdom
Sponsor
Cybin UK Ltd
Condition
Depression
Other study type icon
RecruitingNCT07210255

SAINT in Postpartum Depression (PPD)

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

Multiple locations, including Worcester
DepressionOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Magnus Medical
Condition
Depression
Other study type icon
RecruitingISRCTN94230307

Scaling up care for depression

This study is recruiting in Nigeria. It is testing scaling up care for depression.

In Nigeria
DepressionOtherOver 18 Years
Countries
Nigeria
Sponsor
University of Ibadan
Condition
Depression
Behavioral study icon
RecruitingISRCTN06332944

Schizophrenia Termination Of Pharmacotherapy: STOP-study

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.

In Netherlands
SchizophreniaOther
Countries
Netherlands
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.